SCHEMBL11899240

SCHEMBL11899240

Oc1ccccc1/C=N/Nc1nc(NCc2cccc(Cl)c2)nc(N2CCOCC2)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDX3X O00571 5/20 0.68
▸ MAPK1 P28482 1/20 0.64
▸ NLRP3 Q96P20 1/20 0.64
▸ MAPT P10636 7/20 0.57
▸ TAAR1 Q96RJ0 1/20 0.57
▸ ALDH1A1 P00352 7/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.53
▸ HTT P42858 3/20 0.52
▸ KDM5A P29375 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ LMNA P02545 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ TLR9 Q9NR96 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ PIK3CA P42336 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11899241 1.00 DDX3X (0.68) DDX3XMAPK1NLRP3MAPTTAAR1
SCHEMBL11898926 0.92 DDX3X (0.80) DDX3XMAPK1NLRP3MAPTTAAR1
SCHEMBL11898925 0.92 DDX3X (0.80) DDX3XMAPK1NLRP3MAPTTAAR1
SCHEMBL11898861 0.86 DDX3X (0.81) DDX3XMAPK1NLRP3MAPTTAAR1
SCHEMBL11898862 0.86 DDX3X (0.81) DDX3XMAPK1NLRP3MAPTTAAR1
SCHEMBL1444576 0.84 MAPT (0.69) DDX3XMAPTTAAR1ALDH1A1MEN1
SCHEMBL11961917 0.84 MAPT (0.69) DDX3XMAPTTAAR1ALDH1A1MEN1
SCHEMBL11898710 0.79 HTT (0.63) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL11913671 0.79 DDX3X (0.82) DDX3XMAPTTAAR1ALDH1A1MEN1
SCHEMBL18410102 0.78 KMT2A (0.79) DDX3XMAPK1NLRP3MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B DDX3X 1/4885MAPK1 3143/4885NLRP3 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback